Form D · Pharmaceuticals
IM Cannabis Corp.
Central District, L3 · CIK 0001792030
Offering snapshot reported Nov 20, 2024 · SEC filing
- Reported sold
- $26.9K Offering amount: $67.2K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 12, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 20, 2024 | Initial | $26,893 | No comparison | 1 | SEC filing |
| Jul 9, 2020 | Initial | $302,077 | No comparison | 2 | SEC filing |
| Jul 9, 2020 | Initial | $11,527 | No comparison | 1 | SEC filing |
| Oct 24, 2019 | Initial | $0 | No comparison | 11 | SEC filing |
| Oct 24, 2019 | Initial | $0 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-529927
Total Offering Amount equals price of units (13,003 x C$2.88) plus exercise price of the shares underlying warrants sold in this offering (13,003 x C$4.32). No guarantee that the warrants will be exercised. Exchange rate of CAD$1.00:USD$0.718164
Units consisting of 1 cm sh and 1 cm sh wrt. Each wrt shall be exercisable to acquire 1 cm sh at a price of C$4.32 per wrt for a period of 24 months following the issuance date
Source: Form D, filed Nov 20, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Shmulik Arbel | Director |
| Richard Balla | Executive |
| Vivian Bercovici | Director |
| Uri Birenberg | Executive |
| Rafael Gabay | Director |
| Amir Goldstein | Executive |
| Yael Harrosh | Executive |
| Jesse Kaplan | Director |
| Marc Lustig | Director |
| Moti Marcus | Director |
| Steven Mintz | Director |
| Michal Lebovitz Nissimov | Executive |
| Brian Schinderle | Director |
| Shai Shemesh | Executive |
| Oren Shuster | Director, Executive |
| Einat Zakariya | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
Kibbutz Glil Yam
Central District, L3, 4690500
Central District, L3, 4690500